1 Obesity Research Center, Evans Department of Medicine, and Departments of Biochemistry, 2 Surgery, and 3 Biophysics, Boston University Medical Center, Boston, Massachusetts 02118; 4 Department of Nutrition, University of Montreal, Montreal, Quebec, Canada H2L 4M1; 5 Department of Internal Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania 15261; and 6 Departments of Internal Medicine and Biochemistry, Gifford Laboratories, Center for Diabetes Research, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas 91010
![]() |
ABSTRACT |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Regional differences in free fatty acid (FFA) handling contribute to diseases associated with particular fat distributions. As cultured rat preadipocytes became differentiated, FFA transfer into preadipocytes increased and was more rapid in single perirenal than in epididymal cells matched for lipid content. Uptake by human omental preadipocytes was greater than uptake by abdominal subcutaneous preadipocytes. Adipose-specific fatty acid binding protein (aP2) and keratinocyte lipid binding protein abundance was higher in differentiated rat perirenal than in epididymal preadipocytes. This interdepot difference in preadipocyte aP2 expression was reflected in fat tissue in older animals. Carnitine palmitoyltransferase 1 activity increased during differentiation and was higher in perirenal than in epididymal preadipocytes, particularly the muscle isoform. Long-chain acyl-CoA levels were higher in perirenal than in epididymal preadipocytes and isolated fat cells. These data are consistent with interdepot differences in fatty acid flux ensuing from differences in fatty acid binding proteins and enzymes of fat metabolism. Heterogeneity among depots results, in part, from distinct intrinsic characteristics of adipose cells. Different depots are effectively separate miniorgans.
fatty acid binding protein; free fatty acid uptake; carnitine palmitoyltransferase 1; regional fat distribution
![]() |
INTRODUCTION |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
FAT DISTRIBUTION IN HUMANS varies considerably, even among individuals with the same total body fat content. Particular fat distributions are associated with distinct risks for diabetes, atherosclerosis, dyslipidemia, and hypertension (12, 24, 30, 31, 46, 58-60, 63, 66, 77). For several decades, it has been known that fat tissue is regionally heterogeneous with respect to metabolic function (5). These regional differences in metabolic function probably contribute to the risk profiles of particular fat distributions. Regional differences in endogenous free fatty acid (FFA) handling may be especially important in this regard (41, 42). Fat cells isolated from various rat and human depots differ in size, responses to insulin and lipolytic agents, lipoprotein lipase (LPL) release, lipoprotein binding, de novo lipid synthetic capacity, and fatty acid incorporation, each of which can affect fatty acid handling (5, 27, 29, 36, 40, 58, 59, 74, 80, 83). A particularly intriguing question concerns the fundamental basis of regional variation in fatty acid handling. Is interdepot variation solely a result of influences extrinsic to adipose cells (including their hormonal and paracrine microenvironment, local nutrient availability, innervation, and anatomic constraints), or do intrinsic differences in the innate characteristics of adipose cells also contribute to interdepot variation? Studies in preadipocytes cultured under identical conditions originating from various depots from the same individuals suggest that the latter may be the case (3, 25, 26, 37, 50, 54, 91).
To elucidate the fundamental mechanisms responsible for regional variation in fatty acid handling, we investigated the transfer of exogenous FFA into preadipocytes cultured from different fat depots. There are few reliable methods to measure the transfer of FFA across lipid bilayers. Partly as a result of methodological problems, there is controversy as to the mechanism and rate of transbilayer movement of FFA in plasma membranes (33). Some investigators have hypothesized that FFA require anion transporters to reach the cytoplasmic compartment after their delivery to the outer leaflet of the membrane (87). There is indirect evidence to support the hypothesis of protein-mediated transport, including the cloning of a "fatty acid transport protein" and association of its expression with increased FFA utilization (84, 86). However, this protein is a very long chain acyl-CoA synthetase (21). This may account for its promotion of very long chain fatty acid uptake rather than transporter activity. Two other potential fatty acid transport proteins, mammalian fatty acid binding protein and fatty acid transporter CD36, have since been described and may play a role in fatty acid uptake through direct or indirect mechanisms (1).
An alternative hypothesis is that FFA are capable of rapid diffusion
("flip-flop") across membranes and do not require protein-mediated transport, although membrane proteins may still affect FFA uptake through indirect mechanisms (35). Key tenets of this
theory are that a significant fraction of FFA in a membrane is
un-ionized and that this neutral form of FFA can flip-flop rapidly. If
such passive FFA diffusion occurs across membranes, cytosolic pH
changes should accompany FFA movement (45). This, in fact,
occurs: pH changes in the cytosolic compartment of adipocytes and
pancreatic -cells consistent with the predictions of this model have
been described (18, 34). The mechanisms of
protein-mediated transport and passive diffusion are not necessarily
mutually exclusive. Some investigators hypothesize that
protein-dependent mechanisms are important in determining basal FFA
levels, whereas for high levels of FFA, the diffusion mechanism becomes
important (2). In addition to transbilayer movement, the
amount of fatty acid entering a cell may also depend on the amount of
intracellular fatty acid binding protein available as well as the rate
at which fatty acids are esterified or utilized through
-oxidation
(19).
Within the cell, carnitine palmitoyltransferase 1 (CPT-1) is thought to
be a critical control point in fatty acid metabolism. After conversion
of FFA to long-chain acyl-CoA (LC-CoA), CPT-1 activity determines
whether -oxidation or esterification will occur. There are two
isoforms of CPT-1 whose relative expression varies in different cell
types and as cells undergo differentiation (6, 14, 15, 75, 76,
89). Little is known about effects of fat depot origin on CPT-1
or LC-CoA levels.
To determine whether fat cell anatomic origin results in distinct patterns of fatty acid handling that result from mechanisms intrinsic to the cells themselves, we compared fatty acid uptake, adipose-specific fatty acid binding protein (aP2) and keratinocyte lipid binding protein (KLBP) expression, CPT-1 activity and expression, and LC-CoA levels in differentiating rat preadipocytes, as well as fatty acid uptake in human preadipocytes originating from different depots. We found that fatty acid uptake increased with differentiation, was greater in rat perirenal than in epididymal cells, and was greater in human visceral than in subcutaneous cells. Interdepot and differentiation-dependent differences in preadipocyte fatty acid binding protein expression, CPT-1 isoform expression and activity, and LC-CoA levels were found that could contribute to this intrinsic variation in fatty acid handling. Variation among depots in preadipocyte aP2 abundance in young animals became evident in fat tissue in older animals. This supports the contention that preadipocytes continue to develop into fat cells in adulthood and that intrinsic differences in preadipocyte characteristics contribute to interdepot differences in fat tissue function.
![]() |
METHODS |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Rat preadipocyte cultures.
The epididymal and caudal portion of the perirenal depots of 3- (225-250 g) and 24 (400-450 g)-mo-old, specific pathogen-free Fischer 344 rats were removed. We compared epididymal and perirenal rat
cultures, because purity and recovery have been optimized for these
depots and because large differences in the characteristics of cultures
from these two regions have been described in previous studies
(25, 26, 50, 54, 91). Fat tissue was minced into
fragments, digested in 1 mg/ml of collagenase for 60 min at 37°C, and
filtered (50, 54, 55, 91). After centrifugation of the
digests, the pellets were resuspended in a basal medium [-minimal
essential Eagle's medium (
-MEM) containing 10% fetal bovine serum
(FBS) and antibiotics] and were plated at ~4 × 104
cells/cm2 in culture dishes. After 12 h, a period
during which no replication occurs (25), the adherent
preadipocytes were washed, trypsinized, and replated at a density of
4 × 104 cells/cm2 on coverslips coated
with Cell-Tak (Collaborative Research, Bedford, MA) for single-cell
imaging studies or into 25-cm2 flasks for other studies. We
found that replating 1) reduces mesothelial cell and
macrophage contamination and 2) results in accurate plating
densities [plating density affects capacity of preadipocytes to
differentiate (92)]. Medium was changed every 48 h.
We have previously demonstrated that, by use of these methods, preadipocyte recoveries are similar among depots and that our isolation procedures result in >90% pure populations of
preadipocytes, irrespective of fat depot origin (50).
Brown fat preadipocytes are not present in epididymal or perirenal
(caudal portion) cultures, because uncoupling protein 1 is not evident
in perirenal or epididymal cultures but is observed in interscapular
preadipocyte positive controls (54, 62). We have
previously shown that there are at least two types of preadipocytes in
both rat and human fat, the one capable of more extensively
differentiating than the other (50, 53, 91). The
proportions of each of these subtypes are identical in epididymal and
perirenal preadipocyte cultures (42 ± 3% of perirenal and
43 ± 2% of epididymal preadipocytes were of the extensively
differentiating subtype, and 58 ± 3% and 57 ± 2%,
respectively, were of the less extensively differentiating subtype).
Confluent preadipocyte cultures were differentiated in an enriched
medium containing
-MEM, 2 µM insulin, 10 mM glucose, 5 µl/ml
10% Liposyn III (Abbott, North Chicago, IL), and 20% Nuserum (DM3)
or, in
-MEM, 2 µM insulin, 10 mM glucose, 125 µM indomethacin, and 10% FBS (DM1) (50, 51, 54).
Human preadipocyte preparation and culture.
Fat tissue was resected during abdominal surgical procedures from
subjects who had given informed consent. This protocol was approved by
the Boston University Institutional Review Board for Human Research.
The investigators excluded subjects with malignancies. All subjects had
fasted for 10 h. Two of the subjects were men and four were women.
Subjects were 38.3 ± 2.4 yr of age (mean ± 1 SE; range
33-48). The subjects were moderately obese (body mass index
29 ± 3). Two to ten grams of abdominal subcutaneous (external to
the fascia superficialis) and omental fat were obtained from each
subject. These depots were chosen because major differences have been
found in the characteristics of preadipocytes and fat cells isolated
from them (3, 27, 40, 74, 80). The tissues were minced and
digested in a 1 mg/ml collagenase solution for 30 min, and the
resulting digests were treated with an erythrocyte lysis buffer to
improve subsequent differentiation (38, 90). The cells
were plated for 6 h using a low serum-plating medium [HEPES-buffered DMEM-Ham's F12 (1:1), 0.5% FBS, and antibiotics], washed extensively, and replated at a density of 4 × 104 cells/cm2 (plating efficiency was 50%).
The cells were then cultured on a gel [1.5%
gelatin/phosphate-buffered saline (wt/vol) placed in culture dishes for
24 h that were then washed before cells were plated] in medium
containing 1:1 DMEM-Ham's F12, 100 nM dexamethasone, 500 nM human
insulin, 200 pM triiodothyronine, 30 µM biotin, 17 µM pantothenate,
0.5 µM rosiglitazone, and antibiotics for 2 wk.
CPT-1 activity. Total cellular CPT-1 plus CPT-2 activity in homogenates was determined in the presence of saturating carnitine and LC-CoA while monitoring the production of free CoASH enzymatically (6, 22, 93, 94). CPT-1 activity was measured, as previously described (6), in mitochondrial fractions obtained after purification on a Percoll gradient. Specifically, cells were gently homogenized seven strokes in a glass ten broek homogenizer using a tight-fitting pestle and were then centrifuged at 10,000 g for 10 min. The pellet containing intact mitochondria was washed and resuspended in a 10 mM HEPES, 0.1 M mannitol, 0.25 M sucrose buffer, pH 7.2. CPT-1 activity was measured as the malonyl-CoA-inhibitable formation of palmitoyl carnitine from [3H]carnitine in the presence of 80 µM palmitoyl-CoA and 1 mM carnitine at 30°C during the linear portion of the time course. The reaction was started by the addition of carnitine and was stopped after 6 min by addition of isobutanol plus saturated (NH4)2SO4.
Messenger RNA analysis. RNA was isolated from preadipocytes and collagenase-digested fat cells by use of the guanidinium thiocyanate-phenol method (16). RNA integrity was verified by means of 2% agarose gels. Messenger RNA was measured by Northern blot hybridization as described previously (51, 52, 54, 56, 88).
Western analysis. SDS-PAGE was performed according to the method of Laemmli (65). Either the gels were stained to visualize banding, or the protein was transferred to nitrocellulose for probing. Western analysis was done basically as outlined in Majumder (70). Blotting paper was blocked overnight at 4°C in Tris-buffered saline containing 5% milk. Incubation with the primary polyclonal aP2 and KLBP antibodies (provided by Dr. D. A. Bernlohr, University of Minnesota, St. Paul, MN) was for 1 h at 25°C. The secondary antibody was conjugated to horseradish peroxidase with incubation for 30 min at room temperature. Visualization of the binding of the horseradish peroxidase-conjugated secondary antibody was performed by chemiluminescence. Over the range of protein levels measured, responses were linear for the loading densities employed.
CoA esters. Free CoASH and the total pool of LC-CoA esters were measured enzymatically using published TCA extraction and alkaline hydrolysis techniques (22, 93, 94).
pH measurement and imaging. The fluorescent indicator 2',7'-bis(2-carboxyethyl)-5,(6)-carboxyfluorescein (Molecular Probes, Eugene, OR) was used to measure intracellular pH (pHi) in single cells, as described previously in experiments in which fatty acid movement in groups of cells was monitored (34, 43). Dispersed preadipocytes were loaded with the indicator by a method similar to that described previously (34). Digital imaging analysis of single cells was performed on cells grown on coverslips with the use of a filter changer, a dual wavelength excitation light source (Ionoptix, Milton, MA), and an emission light detection system comprised of an intensified video camera and video data storage (69). Fluorescence was calibrated in terms of pH with the method of Rink et al. (82). In spectrofluorometric studies, oleic acid (NuChekprep, Elysian, MN) in Krebs buffer was added to cells dropwise as complexes with BSA (Sigma, St. Louis, MO; initial fraction by cold alcohol precipitation, essentially fatty acid free; >97% purity by agarose electrophoresis) that had been dialyzed against Krebs buffer. Two oleic acid-to-albumin ratios were used to achieve net partitioning of fatty acids into cells, 8:1 or 6:1. The 8:1 complex delivers more oleic acid to cells than the 6:1 complex, because the 8:1 complex utilizes the low-affinity binding sites on BSA, whereas the 6:1 complex utilizes only the high- and medium-affinity binding sites (17).
Statistical analysis. Northern and Western analysis densitometry data were analyzed by ANOVA with post hoc comparisons by Duncan's multiple range test or paired t-tests as appropriate (44, 47). Statistical analysis of imaging study data was done using applied regression analysis (61) or a two-tailed, unpaired, unequal variance t-test (32). P < 0.05 was considered significant.
![]() |
RESULTS |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Intracellular pH changes were measured by fluorescence to compare
FFA uptake by cells from different depots occurring within the first
few seconds after exposure to FFA and before FFA were metabolized
substantially. The pH experiments were based on the more rapid
flip-flop of the un-ionized form of FA compared with the ionized form
(45). The pH decrease reflects binding of FA to the plasma
membrane, diffusion through the membrane, and dissociation of protons
from the FA that reach the inner leaflet of the plasma membrane. The
extent of pH change after exposure to FFA is a measure of the total
amount of FFA that binds to the plasma membrane and diffuses to the
cytosolic leaflet, as well as properties of the cytoplasmic component,
such as the buffering capacity of the cell and possibly the
concentration of fatty acid binding proteins (33, 34). In
previous studies, we demonstrated pH changes in cell populations in
response to FFA (18, 34), whereas this study is the first
to examine single cells by means of a similar fluorescence approach.
The use of single cells removes potential complications arising from a
heterogeneous population of cells. In single-cell imaging experiments,
we used cells from different depots from the same animals that were
matched for lipid content (determined by measuring numbers and
diameters of lipid inclusions by light microscopy). The extent of the
pH decrease in differentiated rat perirenal preadipocytes
exposed to oleic acid was greater than in epididymal cells (Fig.
1; 0.40 ± 0.02 and 0.26 ± 0.03 pH units in perirenal and epididymal cells, respectively;
P < 0.001 by ANOVA; n = 36 perirenal
cells from 5 animals and 28 epididymal cells from the same animals).
The high ratios of FFA to BSA used in these experiments were intended
to model the delivery of large amounts of FFA to adipocytes, as would
occur during lipolysis of triglyceride-rich lipoproteins in adjacent
capillary endothelial cells, rather than during basal conditions.
|
We also investigated FA uptake by human preadipocytes. In each of six
experiments, differentiated human preadipocytes from the omental region
took up oleic acid more rapidly and extensively than cells derived from
the subcutaneous region (Fig. 2). In
cells from both depots, addition of 180 µM albumin resulted in
partial recovery of pHi, as was observed previously in
pancreatic -cells and rat adipocytes (18, 34). With the
assumption that the extent of pH change reflects total uptake by
diffusion, these variations in FFA uptake confirm that site-specific
differences occur in both the rat and the human.
|
As preadipocytes differentiate into fat cells, they accumulate multiple, small lipid droplets that coalesce into larger droplets. In perirenal preadipocyte cultures from four animals, individual cells were selected that contained large lipid droplets (diameter >6 µm). These cells were compared with cells in the same cultures selected at the same time that contained less lipid in multiple, small droplets (diameter <3 µm). FFA uptake was determined by following the intracellular pH decrease after oleic acid addition to the medium (8:1 complexes of oleic acid-albumin). The decrease in intracellular pH of preadipocytes with extensive lipid stores was 2.5 times that of cells with less lipid (0.23 ± 0.04 vs. 0.09 ± 0.03 pH units in cells with droplets >6 µm vs. those with 3-µm droplets, respectively; P < 0.005 by applied linear regression analysis; n = 18 cells from 6 animals). Hence, initial FFA transfer was greater in preadipocytes that had progressed to the stage of having a few large droplets than in cells with multiple lipid droplets at earlier stages of differentiation.
The larger change in pH in perirenal than in epididymal cells could
reflect, among other possibilities, differences in preadipocyte plasma
membranes (including types and quantities of protein as well as lipid
composition) and/or in the content of intracellular fatty acid binding
proteins among sites. We investigated the latter possibility by
examining the relationship between expression of the intracellular
fatty acid binding proteins aP2 and KLBP and FFA uptake. In comparisons
of cells of different anatomic origin, aP2 mRNA levels were 2.5-fold
higher in differentiated perirenal than epididymal preadipocytes
(n = 12; P < 0.05; Fig.
3). aP2 protein levels were also higher
in differentiated perirenal than epididymal preadipocytes (2.5-fold;
n = 8; P < 0.01; Fig.
4). KLBP expression was 2.2-fold greater
in differentiated perirenal than in epididymal preadipocytes
(n = 5; P < 0.005; Fig. 4). Indeed, in
every experiment, fatty acid binding protein levels were higher in
perirenal than in epididymal cells. As indicated in Fig. 1, FFA uptake
was more extensive in perirenal than in epididymal cells. The
correlation among FFA uptake, aP2 expression, and KLBP levels also held
when undifferentiated preadipocytes were compared with differentiated
cells. Both aP2 and KLBP expression increased with differentiation
[2.4-fold in the case of aP2 (n = 8, P < 0.05) and 2.5-fold in the case of KLBP (n = 5, P < 0.05)], as did FFA uptake (see above). Thus a
positive correlation was found between uptake of FFA and levels of aP2
and KLBP, suggesting that content of FFA binding sites plays a role in
FFA uptake.
|
|
To test the relevance of the interdepot differences in fatty acid
binding protein levels we found in cultured preadipocytes to effects of
depot origin on in vivo fat tissue characteristics, aP2 protein levels
were determined in epididymal and perirenal fat tissue from 3-mo-old
animals (Fig. 5). Although significant statistically, aP2 protein abundance was only slightly higher in
perirenal than in epididymal fat in these animals. However, when aP2
protein abundance was compared between depots from 24-mo-old animals,
levels were 2.6-fold higher in perirenal fat. Hence, interdepot
differences in the characteristics of preadipocytes evident earlier in
life are reflected in fat tissue in later life.
|
Changes in response to differentiation as well as variation between
sites were suggested by a Northern blot of CPT-1 mRNA from rat
epididymal and perirenal preadipocytes pooled from six animals (Fig.
6). Figure 6B (liver CPT-1)
indicates that undifferentiated epididymal preadipocytes expressed low
levels of the liver isoform of CPT-1. Similar data were obtained in
undifferentiated perirenal preadipocytes (data not shown).
Differentiation led to increased total CPT-1 expression. This was
corroborated by measurement of CPT-1 activity, which increased from
0.93 ± 0.06 nmol · mg
protein1 · min
1 in undifferentiated
epididymal cells to 1.73 ± 0.15 nmol · mg
1 · min
1 in
differentiated cells (P < 0.01; Duncan's multiple
range test; n = 4). Perirenal preadipocyte CPT-1
activity also increased during differentiation from 1.34 ± 0.01 to 1.94 ± 0.08 nmol · mg
1 · min
1
(P < 0.01; Duncan's multiple range test;
n = 4). As suggested by the Northern analysis in Fig.
6, total CPT-1 activity was higher in perirenal than in epididymal
cells (P < 0.01; ANOVA; n = 4). The
percentage of the liver isoform appeared greater in epididymal than in
perirenal cells. Figure 6A (muscle CPT-1) shows that little muscle isoform was expressed in undifferentiated preadipocytes. Differentiation led to an increase in the expression of this isoform. The amount of the muscle CPT-1 isoform as a function of total CPT-1 was
higher in perirenal than in epididymal cultures. We had previously
found that mature fat cells expressed high levels of mainly the muscle
isoform (14), confirming the increased expression of this
isoform during differentiation suggested in Fig. 6. Figure
6C (CPT-2) indicates that there were no site- or differentiation-specific differences in CPT-2 expression.
|
A predictable consequence of higher expression of the muscle isoform of CPT-1 is an increased level of cytosolic LC-CoA. Indeed, the amount of LC-CoA was 25% higher in all preparations of differentiated perirenal than epididymal adipocytes obtained from three different groups of rats (172 ± 8 vs. 143 ± 6 pmol/mg protein, respectively; n = 3, P < 0.05, paired t-test). Furthermore, perirenal isolated fat cell LC-CoA (280 ± 10 pmol/mg protein; n = 3, pooled samples from 3 rats) was more than twofold higher than epididymal fat cell LC-CoA (120 ± 10 pmol/mg protein; n = 3, pooled samples from 3 rats, P < 0.05, paired t-test). Hence, interdepot variation in LC-CoA levels became more pronounced once preadipocytes had fully differentiated into fat cells.
![]() |
DISCUSSION |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Differentiating preadipocytes exhibited distinct, depot-dependent patterns of fatty acid uptake and of factors involved in FFA handling (aP2, KLBP, CPT-1 activity and expression, and LC-CoA content). Although it is possible that the local microenvironment of preadipocytes in vivo or factors that contribute to variability of freshly isolated tissues (e.g., vascular, hormonal, and neural effects) have sustained effects on fatty acid handling, the cells were maintained in culture for at least 1 wk before analysis and had undergone at least two population doublings. Hence, effects of these factors seem unlikely to account for the interdepot variation in fatty acid handling that we observed. Although markers of differentiation are lower in epididymal than in perirenal rat mass cultures after the same period of exposure to adipogenic agents (25, 26, 50, 54, 91), differences in fatty acid uptake were observed at the single cell level in cells matched for lipid content. Therefore, although FFA uptake increases with differentiation, variation in extent of differentiation of cultured preadipocytes among depots is not the only factor contributing to interdepot variation in FFA uptake.
Our findings are in accord with those of previous studies that have suggested that interdepot variation in fat cell function reflects differences in the innate characteristics of adipose cells themselves, in addition to effects of variation in nutrient supply, innervation, and other extrinsic factors. Preadipocytes cloned from rat perirenal depots are capable of more extensive replication in vitro and in vivo than preadipocytes from epididymal depots (25, 26, 50, 73, 91). This interdepot variation in preadipocyte replicative capacity is reflected in the extent of increases in fat cell number during fat depot growth in vivo (91). Under a number of different conditions that promote differentiation, perirenal preadipocytes accumulate more lipid and develop higher levels of expression of differentiation-dependent genes than epididymal preadipocytes (25, 50, 54, 91). In the human, abdominal subcutaneous preadipocytes differentiate more extensively than omental preadipocytes after thiazolidinedione treatment (3). Interdepot variation in cultured rat preadipocyte differentiation-dependent gene expression is reflected in differences among depots in fat cell expression of the same genes (54). These interregional differences do not result from variation among depots in preadipocyte recovery, admixture with nonadipose cell types or brown fat preadipocytes, or heterogeneity of preadipocyte subtypes (50, 54, 91). Despite exposure to similar hormonal manipulations in vivo, such as estrogen administration, hypophysectomy, or castration, preadipocytes cultured from various depots retain distinct cell-dynamic and biochemical responses, suggesting that there are site-dependent, intrinsic differences in preadipocyte hormone responsiveness (49, 64). Hence, there appear to be depot-dependent differences in the innate characteristics of adipose cells that could contribute to anatomic variation in function. Our current findings show that, together with differences in capacities for preadipocyte replication and differentiation, there are intrinsic interdepot differences in preadipocyte functional characteristics.
In humans, increased FFA and triglyceride turnover occurs in abdominal compared with peripheral obesity (4, 42, 71). Part of the basis of this difference in FFA flux in vivo may be related to the intrinsic differences in capacity for FFA uptake that we found in preadipocytes cultured from these depots. Because human omental and abdominal subcutaneous fat cells are of similar size in all but obese women (28), the greater capacity for hormone-stimulated lipolysis in omental cells that is associated with interdepot variation at the level of receptor function (67) may be balanced by the increased fatty acid transfer we found into these cells. These interdepot differences in fatty acid flux likely contribute to diminished antilipolytic effects of insulin and other agents in omental compared with abdominal subcutaneous fat cells and greater catecholamine-stimulated lipolysis in isolated omental than in subcutaneous fat cells (4, 5, 60). The insulin resistance associated with visceral obesity probably results, in part, from the FFA released from visceral depots traveling directly to the liver, where they stimulate gluconeogenesis and reduce extraction of insulin. The combination of these effects results in hyperinsulinemia (10, 58, 78, 79, 81).
Variation in LPL activity among depots would affect FFA availability to fat cells. In comparisons among differentiating preadipocytes, isolated fat cells, and fat tissue from various depots in humans and rats, interdepot differences in heparin-released LPL activity have been found, but they are generally small (29, 54, 68, 72). Any such differences in LPL action were bypassed in our studies by exposure of cells directly to fatty acids in serum-free media. Therefore, in addition to any direct effects of variation in LPL release by adipose cells, mechanisms downstream from LPL contribute to interregional variation in FFA transfer.
We found higher levels of aP2 mRNA in differentiated perirenal than epididymal preadipocytes and that aP2 expression increased during differentiation in rat preadipocytes. Increased FFA transfer was correlated with lipid accumulation in differentiating preadipocytes. Hence, there may be an association between aP2 expression and FFA transfer into preadipocytes. Indeed, fatty acids are not taken up efficiently by cardiac myocytes in transgenic mice lacking the heart-type fatty acid binding protein (11). Interestingly, in adipose tissue from aP2 knockout mice, FFA content (as a percentage of adipose tissue mass) was noted to be around twice as great as in wild-type animals (7). It was hypothesized that the absence of aP2 may hamper flux of intracellular pools of FFA out of the adipocyte (7, 20). Also, no differences were found in FFA uptake into adipocytes from wild-type and aP2 knockout mice (20). Because of the species differences and differences in the uptake assay conditions (our assay used much higher FFA-to-albumin ratios, and cells were cultured under conditions that did not favor lipolysis), those results are not necessarily in conflict with ours. Additionally, in the aP2 knockout animals, a 13-fold compensatory upregulation of KLBP partially replaced the fatty acid binding proteins in wild-type animals. Although KLBP in the knockout mice was present in lower abundance than aP2 in wild-type animals, the fatty acid binding efficiency of KLBP is double that of aP2 (85) and may contribute to enhanced FFA uptake into perirenal cells. In cultured rat preadipocytes, lower expression of aP2 in epididymal than in perirenal preadipocytes was not offset by upregulation of KLBP. Indeed, KLBP expression was lower in epididymal than in perirenal cells, as was that of aP2.
Our data indicate that CPT-1 activity is higher in perirenal than in epididymal preadipocytes. Furthermore, LC-CoA levels were higher in differentiated perirenal preadipocytes and fat cells than in epididymal cells. In addition to the enhanced fatty acid uptake in perirenal compared with epididymal cells, the relatively higher CPT-1 muscle isoform expression in perirenal cells indicated in Fig. 6 could explain higher LC-CoA levels in the face of increased CPT-1 activity. Because the muscle isoform of CPT-1 is more sensitive than the liver isoform to malonyl-CoA [the inhibition constant (Ki) of the muscle isoform for malonyl-CoA is 20 nM; the Ki of the liver isoform is 2 µM (23, 95)], differences in isoform expression could contribute to higher LC-CoA levels in perirenal cells. A testable hypothesis arising from this is that CPT-1 isoforms and levels of its allosteric regulators will determine steady-state cytosolic LC-CoA levels, which will in turn determine the rate of LC-CoA esterification.
In addition to the mechanisms discussed above, a number of other processes could contribute to interdepot variation in cultured preadipocyte fatty acid handling. Regional variation in protein-mediated transport [e.g., involving fatty acid transport protein (84), which is a very long chain acyl-CoA synthetase (21)] or in fatty acid composition of cell membranes [which contribute to species differences in inner mitochondrial membrane proton permeability and hence fatty acid utilization (13)] are among these processes. These processes, in turn, may be links along a causal chain of events that begins with more fundamental differences among fat depots in cell programming.
![]() |
PERSPECTIVE |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
From the foregoing discussion, it is likely that adipose tissue heterogeneity results, at least in part, from differences among depots in the intrinsic characteristics of preadipocytes and fat cells. Furthermore, differences among depots in preadipocyte characteristics earlier in life become more evident in fat cells later in life, supporting the contentions that new fat cells continue to develop from preadipocytes in adulthood and that intrinsic characteristics of preadipocytes are reflected in the characteristics of fat tissue that develops from them (8, 9, 39, 48). It is almost as if the preadipocytes (and fat cells derived from them) originating from different regions represent distinct miniorgans.
![]() |
ACKNOWLEDGEMENTS |
---|
The authors acknowledge the technical support by G. Chan and P. Cummins, administrative support by A. O'Brien, and helpful discussions with Dr. G. Yaney and I. Karagiannides. Dr. D. A. Bernlohr kindly provided aP2 and keratinocyte lipid binding protein antibodies.
![]() |
FOOTNOTES |
---|
This work was supported by National Institutes of Health Grants AG/DK-13925 and DK-56891 (J. L. Kirkland), DK-46200 (J. L. Kirkland and B. E. Corkey), DK-18573 (J. D. McGarry), and HL-26335 (J. A. Hamilton), Juvenile Diabetes Foundation Grant 397010 (F. Caserta), and a Canadian Diabetes Association grant (M. Prentki).
Address for reprint requests and other correspondence: J. L. Kirkland, Rm. F435, Boston University Medical Center, 88 E. Newton St., Boston, MA 02118 (E-mail: kirkland{at}bu.edu).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Received 10 March 2000; accepted in final form 27 September 2000.
![]() |
REFERENCES |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
1.
Abumrad, N,
Coburn C,
and
Ibrahimi A.
Membrane proteins implicated in long-chain fatty acid uptake by mammalian cells: CD36, FATP and FABPm.
Biochim Biophys Acta
18:
4-13,
1999.
2.
Abumrad, N,
Harmon C,
and
Ibrahimi A.
Membrane transport of long-chain fatty acids: evidence for a facilitated process.
J Lipid Res
39:
2309-2318,
1998
3.
Adams, M,
Montague CT,
Prins JB,
Holder JC,
Smith SA,
Sanders L,
Digby JE,
Sewter CP,
Lazar MA,
Chatterjee VK,
and
O'Rahilly S.
Activators of peroxisome proliferator-activated receptor gamma have depot-specific effects on human preadipocyte differentiation.
J Clin Invest
100:
3149-3153,
1997
4.
Arner, P.
Differences in lipolysis between human subcutaneous and omental adipose tissues.
Ann Med
27:
435-438,
1995[ISI][Medline].
5.
Arner, P.
Regional adiposity in man.
J Endocrinol
155:
191-192,
1997
6.
Assimacopoulos-Jeannet, F,
Thumelin S,
Roche E,
Esser V,
McGarry JD,
and
Prentki M.
Fatty acids rapidly induce the carnitine palmitoyltransferase I gene in the pancreatic -cell line INS-1.
J Biol Chem
272:
1659-1664,
1997
7.
Bernlohr, DA,
Coe NR,
Simpson MA,
and
Hertzel AV.
Regulation of gene expression in adipose cells by polyunsaturated fatty acids.
Adv Exp Med Biol
422:
145-156,
1997[ISI][Medline].
8.
Bertrand, HA,
Lynd FR,
and
Masoro EJ.
Changes in adipose mass and cellularity through the adult life of rats fed ad libitum or a life-prolonging restricted diet.
J Gerontol A Biol Sci Med Sci
35:
827-835,
1980.
9.
Bertrand, HA,
and
Masoro EJ.
Increasing adipocyte number as the basis for perirenal depot growth in adult rats.
Science
201:
1234-1235,
1978[ISI][Medline].
10.
Bevilacqua, S,
Bonadonna R,
Buzzigoli G,
Boni C,
Ciociaro D,
Maccari F,
Giorico MA,
and
Ferrannini E.
Acute elevation of free fatty acid levels leads to hepatic insulin resistance in obese subjects.
Metabolism
36:
502-506,
1987[ISI][Medline].
11.
Binas, B,
Danneberg H,
McWhir J,
and
Mullins L.
Requirement for the heart-type fatty acid binding protein in cardiac fatty acid utilization.
FASEB J
13:
805-812,
1999
12.
Bouchard, C,
Després JP,
and
Mauriège P.
Genetic and nongenetic determinants of regional fat distribution.
Endocr Rev
14:
72-93,
1993[Abstract].
13.
Brand, M,
Couture P,
Else P,
Withers K,
and
Hulbert A.
Evolution of energy metabolism. Proton permeability of the inner membrane of liver mitochondria is greater in a mammal than in a reptile.
Biochem J
275:
81-86,
1991[ISI][Medline].
14.
Brown, NF,
Hill JK,
Esser V,
Kirkland JL,
Corkey BE,
Foster DW,
and
McGarry JD.
Mouse white adipocytes and 3T3-L1 cells display an anomalous pattern of carnitine palmitoyltransferase (CPT) I isoform expression during differentiation.
Biochem J
327:
225-231,
1997[ISI][Medline].
15.
Chatelain, F,
Kohl C,
Esser V,
McGarry JD,
Girard J,
and
Peforier JP.
Cyclic AMP and fatty acids increase carnitine palmitoyl transferase I gene transcription in cultured fetal rat hepatocytes.
Eur J Biochem
235:
789-798,
1996[Abstract].
16.
Chomczynski, P,
and
Sacchi N.
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.
Anal Biochem
162:
156-159,
1987[ISI][Medline].
17.
Cistola, DP,
Small DM,
and
Hamilton JA.
Carbon 13 NMR studies of saturated fatty acids bound to bovine serum albumin.
J Biol Chem
262:
10971-10979,
1987
18.
Civelek, VN,
Hamilton JA,
Tornheim K,
and
Corkey BE.
Intracellular pH in adipocytes: effects of free fatty acid diffusion across the plasma membrane, lipolytic agonists, and insulin.
Proc Natl Acad Sci USA
93:
10139-10144,
1996
19.
Coe, NR,
and
Bernlohr DA.
Physiological properties and functions of intracellular fatty acid-binding proteins.
Biochim Biophys Acta
1391:
287-306,
1998[ISI][Medline].
20.
Coe, NR,
Simpson MA,
and
Bernlohr DA.
Targeted disruption of the adipocyte lipid-binding protein (aP2 protein) gene impairs fat cell lipolysis and increases cellular fatty acid levels.
J Lipid Res
40:
967-972,
1999
21.
Coe, NR,
Smith A,
Frohnert B,
Watkins P,
and
Bernlohr D.
The fatty acid transport protein (FATP1) is a very long chain acyl-CoA synthetase.
J Biol Chem
274:
36300-36304,
1999
22.
Corkey, BE.
Analysis of acyl-coenzyme A esters in biological samples.
Methods Enzymol
166:
55-70,
1988[ISI][Medline].
23.
Declercq, PE,
Falck JR,
Kuwajima M,
Tyminski H,
Foster DW,
and
McGarry JD.
Characterization of the mitochondrial carnitine palmitoyltransferase enzyme system. I. Use of inhibitors.
J Biol Chem
262:
9812-9821,
1987
24.
Després, JP.
The insulin resistance-dyslipidemic syndrome of visceral obesity: effect on patients' risk.
Obesity Res
6, Suppl1:
8S-17S,
1998[Abstract].
25.
Djian, P,
Roncari DAK,
and
Hollenberg CH.
Influence of anatomic site and age on the replication and differentiation of rat adipocyte precursors in culture.
J Clin Invest
72:
1200-1208,
1983[ISI][Medline].
26.
Djian, P,
Roncari DAK,
and
Hollenberg CH.
Adipocyte precursor clones vary in capacity for differentiation.
Metabolism
34:
880-883,
1985[ISI][Medline].
27.
Edens, NK,
Fried SK,
Kral JG,
Hirsch J,
and
Leibel RL.
In vitro lipid synthesis in human adipose tissue from three abdominal sites.
Am J Physiol Endocrinol Metab
265:
E374-E379,
1993
28.
Fried, S,
and
Kral J.
Sex differences in regional distribution of fat cell size and lipoprotein lipase activity in morbidly obese patients.
Int J Obes
11:
129-140,
1987[ISI][Medline].
29.
Fried, SK,
Russell CD,
Grauso NL,
and
Brolin RE.
Lipoprotein lipase regulation by insulin and glucocorticoid in subcutaneous and omental adipose tissues of obese women and men.
J Clin Invest
92:
2191-2198,
1993[ISI][Medline].
30.
Fujioka, S,
Matsuzawa Y,
Tokunaga K,
Kawamoto T,
Kobatake T,
Keno Y,
Kotani K,
Yoshida S,
and
Tarui S.
Improvement of glucose and lipid metabolism associated with selective reduction of intra-abdominal visceral fat in premenopausal women with visceral fat obesity.
Int J Obes
15:
853-859,
1990.
31.
Gillum, RF.
The association of body fat distribution with hypertension, hypertensive heart disease, coronary heart disease, diabetes and cardiovascular risk factors in men and women aged 18-79 years.
J Chron Dis
40:
421-428,
1987[ISI][Medline].
32.
Glantz, SA.
Primer of Biostatistics. New York: McGraw-Hill, 1992.
33.
Hamilton, JA.
Fatty acid transport: easy or difficult.
J Lipid Res
39:
467-481,
1998
34.
Hamilton, JA,
Civelek VN,
Kamp F,
Tornheim K,
and
Corkey B.
Changes in internal pH caused by movement of fatty acids into and out of pancreatic -cells (HIT).
J Biol Chem
269:
20852-20856,
1994
35.
Hamilton, JA,
and
Kamp F.
How are free fatty acids transported in membranes: by protein transport or by free diffusion?
Diabetes
48:
2255-2269,
1999[Abstract].
36.
Hartman, AD.
Adipocyte fatty acid mobilization in vivo: effects of age and anatomical location.
Lipids
20:
255-261,
1985[ISI][Medline].
37.
Hauner, H,
and
Entemann G.
Regional variation of adipose differentiation in cultured stromal-vascular cells from the abdominal and femoral adipose tissue of obese women.
Int J Obes
15:
121-126,
1991[ISI][Medline].
38.
Hauner, H,
Entenmann G,
Wabitsch M,
Gaillard D,
and
Ailhaud G.
Promoting effect of glucocorticoids on the differentiation of human adipocyte precursor cells cultured in a chemically defined medium.
J Clin Invest
84:
1663-1670,
1989[ISI][Medline].
39.
Hollenberg, CH,
and
Vost A.
Regulation of DNA synthesis in fat cells and stromal elements from rat adipose tissue.
J Clin Invest
47:
2485-2498,
1968[ISI].
40.
Hube, F,
Lietz U,
Igel M,
Jensen PB,
Tornqvist H,
Joost HG,
and
Hauner H.
Difference in leptin mRNA levels between omental and subcutaneous abdominal adipose tissue from obese humans.
Horm Metab Res
28:
690-693,
1996[ISI][Medline].
41.
Jensen, MD.
Diet effects on fatty acid metabolism in lean and obese humans.
Am J Clin Nutr
67, Suppl3:
531S-534S,
1998[Abstract].
42.
Jensen, MD,
Haymond MW,
Rizza RA,
Cryer PE,
and
Miles JM.
Influence of body fat distribution on free fatty acid metabolism in obesity.
J Clin Invest
83:
1168-1173,
1989[ISI][Medline].
43.
Juntti-Berggren, L,
Tornheim K,
Corkey BE,
and
Berggren PO.
Regulation of intracellular pH in the pancreatic -cell.
In: Frontiers of Pancreatic
-Cell Research, edited by Flatt PR. Amsterdam, The Netherlands: Elsevier, 1994.
44.
Kachigan, SK.
Statistical Analysis. New York: Radius, 1986.
45.
Kamp, F,
and
Hamilton JA.
pH gradients across phospholipid membranes caused by fast flip-flop of un-ionized fatty acids.
Proc Natl Acad Sci USA
89:
11367-11370,
1992[Abstract].
46.
Kannel, WB,
Cupples LA,
Ramaswami R,
Stokes J,
Kreger BE,
and
Higgins M.
Regional obesity and risk of cardiovascular disease: the Framingham study.
J Clin Epidemiol
44:
183-190,
1991[ISI][Medline].
47.
Keppel, G.
Design and Analysis: A Researcher's Handbook. Englewood Cliffs, NJ: Prentice-Hall, 1973.
48.
Kirkland, JL,
and
Dobson DE.
Preadipocyte function and aging: links between age-related changes in cell dynamics and altered fat cell function.
J Am Geriatr Soc
45:
959-967,
1997[ISI][Medline].
49.
Kirkland, JL,
Hollenberg CH,
Gillon W,
and
Kindler S.
Effect of hypophysectomy on rat preadipocyte replication and differentiation.
Endocrinology
131:
2769-2773,
1992[Abstract].
50.
Kirkland, JL,
Hollenberg CH,
and
Gillon WS.
Age, anatomic site, and the replication and differentiation of adipocyte precursors.
Am J Physiol Cell Physiol
258:
C206-C210,
1990
51.
Kirkland, JL,
Hollenberg CH,
and
Gillon WS.
Ageing, differentiation, and gene expression in rat epididymal preadipocytes.
Biochem Cell Biol
71:
556-561,
1993[ISI][Medline].
52.
Kirkland, JL,
Hollenberg CH,
and
Gillon WS.
Effects of aging on ribosomal protein L7 messenger RNA levels in cultured rat preadipocytes.
Exp Gerontol
28:
557-563,
1993[ISI][Medline].
53.
Kirkland, JL,
Hollenberg CH,
and
Gillon WS.
Two preadipocyte subtypes cloned from human omental fat.
Obes Res
1:
87-91,
1993.
54.
Kirkland, JL,
Hollenberg CH,
and
Gillon WS.
Effects of fat depot site on differentiation-dependent gene expression in rat preadipocytes.
Int J Obes
20:
S102-S107,
1996[ISI].
55.
Kirkland, JL,
Hollenberg CH,
Kindler S,
and
Gillon WS.
Effects of age and anatomic site on preadipocyte number in rat fat depots.
J Gerontol A Biol Sci Med Sci
49:
B31-B35,
1994.
56.
Kirkland, JL,
Hollenberg CH,
Kindler S,
and
Roncari DAK
Long chain fatty acids decrease lipoprotein lipase activity of cultured rat adipocyte precursors.
Metabolism
43:
1-5,
1994[ISI][Medline].
57.
Kirkland, JL,
Piñeyro MA,
Lu Z,
and
Gregerman RI.
Hormone sensitive adenylyl cyclase in preadipocytes cultured from adipose tissue: comparison with 3T3-L1 cells and adipocytes.
J Cell Physiol
133:
449-460,
1987[ISI][Medline].
58.
Kissebah, AH,
and
Hennes MMI
Central obesity and free fatty acid metabolism.
Prostaglandins Leukotrienes Essent Fatty Acids
52:
209-211,
1995[ISI][Medline].
59.
Kissebah, AH,
and
Krakower GR.
Regional adiposity and morbidity.
Physiol Rev
74:
761-811,
1994
60.
Kissebah, A,
Vydelingum N,
Murray R,
Evans DJ,
Hartz AJ,
Kalkhoff RK,
and
Adams PW.
Relation of body fat distribution to metabolic complications of obesity.
J Clin Endocrinol Metab
54:
254-260,
1982[Abstract].
61.
Kleinbaum, D,
Kupper L,
and
Muller K.
Applied Regression Analysis and Other Multivariate Methods. Belmont, CA: Duxbury, 1998.
62.
Kozak, VC,
and
Kozak LP.
Norepinephrine-dependent selection of brown adipocyte cell lines.
Endocrinology
134:
906-913,
1994[Abstract].
63.
Krokiewski, M,
Björntorp P,
Sjöström L,
and
Smith U.
Impact of obesity on men and women: importance of regional adipose tissue distribution.
J Clin Invest
72:
1150-1162,
1983[ISI][Medline].
64.
Lacasa, D,
Garcia E,
Agli B,
and
Giudicelli Y.
Control of rat preadipocyte adipose conversion by ovarian status: regional specificity and possible involvement of the mitogen-activated protein kinase-dependent and c-fos signaling pathways.
Endocrinology
138:
2729-2734,
1997
65.
Laemmli, UK.
Cleavage of structural proteins during the assembly of the head of the bacteriophage T4.
Nature
227:
680-685,
1970[ISI][Medline].
66.
Lapidus, L,
Bengtsson C,
Larsson B,
Pennert K,
Rybo E,
and
Sjostrom L.
Distribution of adipose tissue and risk of cardiovascular disease and death: a 12 year follow up of participants in the population study of women in Gothenberg, Sweden.
Br Med J
289:
1257-1261,
1984[ISI][Medline].
67.
Large, V,
and
Arner P.
Regulation of lipolysis in humans. Pathophysiological modulation in obesity, diabetes, and hyperlipidaemia.
Diabetes Metab
24:
409-418,
1998[ISI][Medline].
68.
Lefebvre, AM,
Laville M,
Vega N,
Riou JP,
van Gaal L,
Auwerx J,
and
Vidal H.
Depot-specific differences in adipose tissue gene expression in lean and obese subjects.
Diabetes
47:
98-103,
1998[Abstract].
69.
Longo, EA,
Tornheim K,
Deeney JT,
Varnum BA,
Tillotson D,
Prentki M,
and
Corkey BE.
Oscillations in cytosolic free Ca2+, oxygen consumption, and insulin secretion in glucose-stimulated rat pancreatic islets.
J Biol Chem
266:
9314-9319,
1991
70.
Majumdar, S.
Protein kinase C isotypes and signaling in neutrophils.
J Biol Chem
266:
9285-9294,
1991
71.
Mårin, P,
Andersson B,
and
Ottoson M.
The morphology and metabolism of intraabdominal adipose tissue in man.
Metabolism
11:
1242-1248,
1993.
72.
Mårin, P,
Oden B,
and
Björntorp P.
Assimilation and mobilization of triglyceride in subcutaneous abdominal and femoral adipose tissue in vivo in men: effects of androgens.
J Clin Endocrinol Metab
80:
239-243,
1995[Abstract].
73.
Miller, WH,
Faust IM,
and
Hirsch J.
Demonstration of de novo production of adipocytes in adult rats by biochemical and radioautographic techniques.
J Lipid Res
25:
336-347,
1984[Abstract].
74.
Montague, CT,
Prins JB,
Sanders L,
Digby JE,
and
O'Rahilly S.
Depot- and sex-specific differences in human leptin mRNA expression: implications for the control of regional fat distribution.
Diabetes
46:
342-347,
1997[Abstract].
75.
Mynatt, RL,
and
Cook GA.
Changes in carnitine palmitoyl I mRNA abundance produced by hyperthyroidism and hypothyroidism parallel changes in activity.
Biochem Biophys Res Commun
201:
931-937,
1994.
76.
Park, EA,
Mynatt RI,
Cook GA,
and
Kashfi K.
Insulin regulates enzyme activity, malonyl CoA sensitivity and mRNA abundance of carnitine palmitoyl transferase I.
Biochem J
310:
853-858,
1995[ISI][Medline].
77.
Peiris, AN,
Hennes MI,
Evans DJ,
Wilson CR,
Lee MB,
and
Kissebah AH.
Relationship of anthropometric measurements of body fat distribution to metabolic profile in premenopausal women.
Acta Med. Scand.
723, Suppl:
179-188,
1988.
78.
Peiris, AN,
Mueller RA,
Smith GA,
Struve MF,
and
Kissebah AH.
Splanchnic insulin metabolism in obesity.
J Clin Invest
78:
1648-1657,
1986[ISI][Medline].
79.
Peiris, AN,
Struve MF,
and
Kissebah AH.
Relationship of body fat distribution to the metabolic clearance of insulin in obese women.
Int J Obes
11:
581-589,
1987[ISI][Medline].
80.
Prins, JB,
and
O'Rahilly S.
Regulation of adipose cell number in man.
Clin Sci (Colch)
92:
3-11,
1997[ISI][Medline].
81.
Randle, P,
Garland P,
Hales C,
and
Newsholme E.
The glucose-fatty acid cycle. Its role in insulin sensitivity.
Lancet
i:
785-789,
1963.
82.
Rink, TJ,
Tsien RY,
and
Pozzan J.
Cytoplasmic pH and free Mg2+ in lymphocytes.
Cell Biol Int
95:
189-196,
1982.
83.
Salter, AM,
Fong BS,
Jimenez J,
Rotstein L,
and
Angel A.
Regional variation in high-density lipoprotein binding to human adipocyte plasma membranes of massively obese subjects.
Eur J Clin Invest
17:
16-22,
1987[ISI][Medline].
84.
Schaffer, JE,
and
Lodish HF.
Expression cloning and characteristics of a novel adipocyte long chain fatty acid transport protein.
Cell
79:
427-436,
1994[ISI][Medline].
85.
Shaughnessy S, Smith E, Kodukula S, Storch J, and Fried SK.
Adipocyte metabolism in adipocyte fatty acid binding protein knockout
(aP2-/-) mice after short-term high-fat feeding: functional
compensation by keratinocyte fatty acid binding protein.
Diabetes. In press.
86.
Storch, J,
Lechene C,
and
Kleinfeld AM.
Direct determination of fatty acid transport across the adipocyte plasma membrane using quantitative fluorescence microscopy.
J Biol Chem
266:
13473-13476,
1991
87.
Stremmel, W,
Strohmeyer G,
and
Berk PD.
Hepatocellular uptake of oleate is energy dependent, sodium linked, and inhibited by an antibody to a hepatocyte plasma membrane fatty acid binding protein.
Proc Natl Acad Sci USA
83:
3584-3588,
1986[Abstract].
88.
Teichert-Kuliszewska, K,
Hamilton BS,
Roncari DAK,
Kirkland JL,
Gillon WS,
Deitel M,
and
Hollenberg CH.
Increasing vimentin expression associated with differentiation of human and rat preadipocytes.
Int J Obes
20, Suppl2:
S108-S113,
1996[ISI].
89.
Thumelin, S,
Esser V,
Charvy D,
Kolodziez M,
Zammit VA,
McGarry JD,
Girard J,
and
Pegorier JP.
Expression of liver carnitine palmitoyl I and II genes during development in the rat.
Biochem J
300:
583-587,
1994[ISI][Medline].
90.
Van de Ventner, M,
Litthauer D,
and
Oelofsen W.
Catecholamine stimulated lipolysis in differentiated human preadipocytes in a serum-free, defined medium.
J Cell Biochem
54:
1-10,
1994[ISI][Medline].
91.
Wang, H,
Kirkland JL,
and
Hollenberg CH.
Varying capacities for replication of rat adipocyte precursor clones and adipose tissue growth.
J Clin Invest
83:
1741-1746,
1989[ISI][Medline].
92.
Wiederer, O,
and
Löffler G.
Hormonal regulation of the differentiation of rat adipocyte precursor cells in primary culture.
J Lipid Res
28:
649-658,
1987[Abstract].
93.
Williamson, JR,
and
Corkey BE.
Assay of citric acid cycle intermediates and related compounds.
Methods Enzymol
13:
434-513,
1969.
94.
Williamson, JR,
and
Corkey BE.
Assay of citric acid cycle intermediates and related compoundsupdate with tissue metabolite levels and intracellular distribution.
Methods Enzymol
55:
200-222,
1979[Medline].
95.
Woeltje, KF,
Esser V,
Weis BC,
Cox WF,
Schroeder JG,
Liao ST,
Foster DW,
and
McGarry JD.
Inter-tissue and inter-species characteristics of the mitochondrial carnitine palmitoyltransferase enzyme system.
J Biol Chem
265:
10714-10719,
1990
96.
Zapata, JM,
Takahashi R,
Salvesen GS,
and
Reed JC.
Granzyme release and caspase activation in activated human T-lymphocytes.
J Biol Chem
273:
6916-6920,
1998